Capital Wealth Alliance’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Capital Wealth Alliance’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,506	Closed	-$232K	–	108
2024 Q1	$232K	Buy	+1,506	New	+$230K	0.14%	85
2023 Q3	–	Sell	-1,927	Closed	-$295K	–	102
2023 Q2	$295K	Buy	1,927 +63	+3%	+$9.82K	0.22%	79
2023 Q1	$289K	Buy	+1,864	New	+$293K	0.23%	82
2020 Q4	–	Sell	-1,857	Closed	-$292K	–	124
2020 Q3	$292K	Buy	1,857 +46	+3%	+$7.52K	0.26%	76
2020 Q2	$303K	Buy	+1,811	New	+$284K	0.31%	68
2020 Q1	–	Sell	-11	Closed	-$2K	–	164
2019 Q4	$2K	Buy	+11	New	+$1.51K	﹤0.01%	308

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Capital Wealth Alliance's FBT Position: Q2 2024 in Review

Capital Wealth Alliance sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2024, closing a stake of 1,506 shares — an estimated $232K sold.

Capital Wealth Alliance first reported a position in FBT in Q4 2019 and held it in 6 quarters. The position peaked at $303K in Q2 2020. 251 funds tracked by Wall St. Rank hold FBT as of Q2 2024.

Capital Wealth Alliance reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2024 after selling out during the quarter.
Capital Wealth Alliance sold 1,506 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2024, an estimated $232K.
Capital Wealth Alliance first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2019 and held it in 6 quarters.
Capital Wealth Alliance's First Trust NYSE Arca Biotechnology Index Fund position peaked at $303K in Q2 2020.
251 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2024.

Based on Capital Wealth Alliance's 13F filing for Q2 2024, filed 24 Jul 2024.